Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq

Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq


Eurocept today announces an important step in its growth. Founder Mike van Woensel and Gimv sell their stake in Eurocept Homecare to Mediq. Mediq is part of Mediq Group, a leading international provider of medical devices and healthcare services, headquartered in Utrecht (NL). This acquisition enables Mediq to broaden its portfolio of healthcare services and strengthen its position in home health care in the Benelux.

In 2014 Gimv acquired a minority stake in the capital of Eurocept Homecare (Houten - NL,, a pioneer in the provision of specialist medical home treatments in the Netherlands. In recent years, the company has been able to record a good growth story, among other things by expanding its product and service portfolio into a full 'Hospital-at-home' offering with nutrition, home/kidney dialysis, infusion care, complex wound care and oncology aftercare. All this is done in close cooperation with hospitals, medical specialists as well as pharma companies via the so-called care pathways. Through buy-and-build, including the strategic acquisitions of Medizorg, Jadim and the Da Vinci Clinic, the services have been expanded (e.g. diabetes, kidney dialysis at home, oncological aftercare and complex wound care) and Eurocept Homecare was able to further scale up to become one of the most innovative medical home care companies in Europe. 

Since its inception in 2001, Eurocept Homecare has continually invested in staff, care pathways and product offerings with the aim of relieving hospitals of the burden by efficiently transferring care to the patient's home situation. The company currently employs around 400 people, including 150 highly qualified nurses and six clinics for complex wound care and oncology aftercare, serving more than 30,000 patients a year.

Mike van Woensel, CEO and founder of Eurocept Group, says: "The momentum of acquisition by Mediq is good in my opinion. Patients and doctors have every interest in the accelerated provision of care outside the hospital. Mediq has a perfect infrastructure with state-of-the-art medical device ordering platforms and a modern fulfillment center. This, combined with Eurocept's innovations for hospital-at-home care and the value-driven specialist medical care of the Da Vinci clinics, is the best of both worlds. It enables us to provide the necessary speed and quality at an acceptable cost for the medical specialist, the patient and society at large. Gimv has always supported our growth ambitions and assisted the management in strategic choices."

Elderd Land, Partner in Gimv's Health & Care platform, about this growth story: "We are proud that we were able to support Eurocept as an innovative company in its expansion, resulting in beautiful growth and a position as a unique player in 'Hospital-at-home' concepts. The vision and determination of Mike van Woensel and his team were absolutely vital in this respect. The acquisition by Mediq is a logical next step for Eurocept Homecare: a further broadening of the offer and the connection with a respected player with a long history in the Netherlands will ensure that the unique concept of home care can be further rolled out. This is a win-win for all parties involved: the patient, the hospital, the care company and society as a whole."

The transaction is subject to the usual terms and conditions, including the approval of the healthcare and competition authorities. It has no significant impact on the Net Asset Value of Gimv as of 31 March 2020. No further financial details will be disclosed.